Your browser doesn't support javascript.
loading
Research on the effect of interfering with miRNA-155 on triple-negative breast cancer cells.
Hu, Yangying; Wu, Deqi; Feng, Xiangjun; Shi, Zhijie.
Affiliation
  • Hu Y; Department of Thyroid and Breast Diagnosis and Treatment Center, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 310000, China.
  • Wu D; Department of Thyroid and Breast Diagnosis and Treatment Center, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 310000, China.
  • Feng X; Department of Geriatrics General Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, 650032, China.
  • Shi Z; Department of Thyroid and Breast Diagnosis and Treatment Center, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 310000, China. szjsljr@163.com.
Genes Genomics ; 44(9): 1117-1124, 2022 09.
Article in En | MEDLINE | ID: mdl-33909229

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Genes Genomics Year: 2022 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: MicroRNAs / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Genes Genomics Year: 2022 Type: Article Affiliation country: China